Genzyme Corporation, Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in 1981, Genzyme has established itself as a leader in developing innovative therapies for rare genetic disorders, multiple sclerosis, and other serious conditions. The company operates primarily in North America and Europe, focusing on areas such as enzyme replacement therapy and gene therapy. Genzyme's core products, including Cerezyme and Fabrazyme, are distinguished by their ability to address unmet medical needs, providing patients with life-altering treatments. With a strong commitment to research and development, Genzyme has achieved significant milestones, including its acquisition by Sanofi in 2011, which further solidified its market position. Renowned for its dedication to patient care and scientific advancement, Genzyme continues to make a meaningful impact in the biopharmaceutical landscape.
We don't have data for Genzyme Corporation, Inc., but we can show you information about their parent organization instead.
View parent company